- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Status
Ongoing
Phase
III
IIb
Principal Investigator(s)
Glenda Gray, MBBCH, FCPaed (SA)
Objective
This study will evaluate the preventive vaccine efficacy, safety, and tolerability of ALVAC-HIV (vCP2438) + Bivalent Subtype C gp120/MF59 in HIV-seronegative South African adults over 24 months and potentially up to 36 months from enrollment.
*Vaccinations have stopped early due to non-efficacy but participants are still being followed
Last updated Aug 25, 2021
Prevention Option(s)
HIV Vaccine
Study Design
Randomized
Double-blind
Arms and Assigned Interventions
Description
Active Comparator: ALVAC-HIV + subtype C gp120/MF59
2700 participants will receive an IM injection of ALVAC-HIV (vCP2438) at months 0 and 1, and an IM injection of ALVAC-HIV (vCP2438) + Bivalent Subtype C gp120/MF59 at months 3, 6, and 12.
Mode of Delivery
Intramuscular
Products
ALVAC
gp120
ARMs
Experimental
Clade
C
Description
Placebo Comparator: Placebo
2700 participants will receive Sodium Chloride for injection, 0.9% at months 0, 1, 3, 6, and 12.
Mode of Delivery
Intramuscular
ARMs
Placebo Comparator
Official Code
Related Publications
Trial Sponsors
NIAID, Bill and Melinda Gates Foundation, GlaxoSmithKline, Sanofi
October 2016
September 2021
Enrollment
5 407
18
Years
35
Years
Population
Men
Women
Sites
Madibeng Centre for Research
Brits
South Africa
Emavundleni (EMA) CRS
Cape Town
South Africa
Khayelitsha CRS
Cape Town
South Africa
eThekwini CRS
Durban, KwaZulu-Natal
South Africa
Isipingo CRS
Westville, KwaZulu-Natal
South Africa
Verulam CRS
Verulam, KwaZulu-Natal
South Africa
Klerksdorp
South Africa
Aurum Institute
Klerksdorp
South Africa
Soweto HVTN CRS
Johannesburg
South Africa
Rustenburg CRS
Rustenburg
South Africa
Setshaba Research Centre
Shoshanguve
South Africa
Kliptown
Soweto
South Africa
The Aurum Institute, Tembisa Hospital
Tembisa
South Africa
MeCRU CRS
Pretoria
South Africa
Qhakaza Mbokodo Research Clinic
Ladysmith
South Africa